Pharma Marketing News Vol. 12, No. 2: 20 February 2013 | Pharma Marketing Network
Home Articles 2013 Pharma Marketing News Vol. 12, No. 2: 20 February 2013
Vol. 12, Issue No. 2: 20 FEBRUARY 2013 – EXECUTIVE SUMMARY Welcome to Volume 12, Issue No. 2 (20 February 2013) of Pharma Marketing News. Thank you for being a subscriber. See the featured article summaries below.
@pharmaguy Reigning in the “Wild West” of Mobile Health Apps Will It Be FDA Regulation or Self-Regulation or Both?
In the early days of the Internet hundreds of health Web sites of questionable quality proliferated without any guarantee of accuracy, lack of bias, privacy, etc. Today, thousands of mobile health apps of unknown quality are available for downloading by healthcare professionals and consumers.
As with Web sites in the early days, it is difficult today for users of mobile health apps to be assured that the apps are reliable, accurate, based on valid information, and adequately safeguard users’ information. In many ways, we are living through another digital “wild west” without any sheriffs to protect us.
And it appears that we do need protection.
Inaccurate Health Apps
Overzealous FDA Regulation?
The Regulation of Pharma Health Apps Survey Results
Good App Privacy Practices
Possibly the First Ever “Dear Doctor’ Letter Regarding a Recall Mobile Medical App
Certification of Mobile Health Apps
Will Regulation Kill Innovation?
Self-Regulation: Devil’s in the Details
Will Ethics Revive (Exhume?) the Drug Industry’s Reputation? Excellence in Ethics Accreditation Proposed for Pharma
We all know why the drug industry has a bad reputation. For one thing, it has been found guilty of unethical and even unlawful practices that include hiding clinical trial data and illegally marketing drugs. How to improve the industry’s reputation is a perrenial question.
So it was with great interest that I read about a new effort to improve the drug industry’s reputation: the establishment by a bioethicist of an accreditation rating system.
Jennifer Miller, a fellow at the Edmund J Safra Center for Ethics at Harvard University and president of Bioethics International, a non-profit that advises educational programs on ethical issues on medicine and healthcare, is trying to develop the industry equivalent of a “Good Housekeeping Seal of Approval.” This article summarizes her ideas and presents opinions of several naysayers.
A Pharma Industry Seal of Approval
Achilles’ Heel: Credibility of the Seal
Excellence in Ethics Accreditation